A clinical study in individuals with Amyotrophic Lateral Sclerosis (ALS)

CONDITION

Neurological

GENDER

Both males and females

AGE GROUP

From 18

to 75 years

STATUS

Recruiting

About this clinical trial: Wesley Medical Research is seeking research participants for a study evaluating the safety and tolerability of an investigational drug for Amyotrophic lateral sclerosis (ALS) and how it is absorbed in the body. ALS is a rare and progressive neuromuscular disease for which there is currently no cure.

 

Eligibility:

You may be eligible to participate if you meet the following conditions:

  • 18-75 years of age
  • Either diagnosed with or suspected of having ALS
  • Can attend 4 study visits over 6 weeks

 

If you are interested in learning more about this study, please enter your details in the contact form on this page. Eligible participants will receive the investigational drug by subcutaneous injection, undergo study-related procedures, and receive compensation for time.

CONTACT DETAILS

Clinical Trial Site: Wesley Medical Research
Phone Number: 07 3721 1500 Email: Jacqui.Langton@wesleyresearch.org.au Location: Wesley Medical Research, Coronation Drive, Auchenflower QLD, Australia
  • Hidden

Approved By: HREC              

Clinical Trial Registry Link: